Skip to content

Fosamprenavir: US approves once-daily dose with less ritonavir boosting

Atripla takes a key step towards European approval

Liver fibrosis often progresses rapidly in HIV/HCV co-infected; elevated AST levels best predictor

PEPFAR money being used to 'promote homophobia', charges human rights group

Financial worries predict poor adherence to anti-HIV therapy in US patients

Hypersensitivity reaction in patient taking Truvada with similar symptoms to abacavir allergy

Palliative care: pain and symptom control being ignored in South Africa due to lack of training, legal barriers

Up to 40% of ART recipients in Africa have died or discontinued treatment within two years

Why are many US patients presenting later for HIV testing and care today than in 1990?